Dimensional Fund Advisors LP raised its stake in Orthofix International N.V. (NASDAQ:OFIX) by 2.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 779,771 shares of the medical device company’s stock after buying an additional 20,473 shares during the period. Dimensional Fund Advisors LP’s holdings in Orthofix International N.V. were worth $29,748,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. UBS Asset Management Americas Inc. acquired a new position in Orthofix International N.V. during the first quarter valued at $229,000. Comerica Bank acquired a new position in Orthofix International N.V. during the first quarter valued at $783,000. BNP Paribas Arbitrage SA boosted its position in Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock valued at $178,000 after buying an additional 1,900 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Orthofix International N.V. by 122.5% in the first quarter. Bank of New York Mellon Corp now owns 242,068 shares of the medical device company’s stock valued at $9,236,000 after buying an additional 133,281 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in Orthofix International N.V. by 68.9% in the first quarter. American Century Companies Inc. now owns 175,522 shares of the medical device company’s stock valued at $6,696,000 after buying an additional 71,599 shares in the last quarter. Hedge funds and other institutional investors own 99.96% of the company’s stock.
Orthofix International N.V. (OFIX) traded down 0.05% during mid-day trading on Thursday, reaching $43.03. The company had a trading volume of 3,223 shares. Orthofix International N.V. has a 52 week low of $32.51 and a 52 week high of $48.25. The firm’s market capitalization is $776.43 million. The stock’s 50-day moving average price is $45.55 and its 200 day moving average price is $40.42.
Orthofix International N.V. (NASDAQ:OFIX) last posted its quarterly earnings data on Thursday, May 4th. The medical device company reported $0.27 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.27. The firm had revenue of $102.70 million during the quarter, compared to analysts’ expectations of $97.17 million. Orthofix International N.V. had a positive return on equity of 10.03% and a negative net margin of 0.82%. The business’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.28 EPS. On average, equities research analysts predict that Orthofix International N.V. will post $1.53 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/03/orthofix-international-n-v-ofix-stake-boosted-by-dimensional-fund-advisors-lp.html.
Several research analysts have recently weighed in on the company. BidaskClub cut Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research upgraded Orthofix International N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, July 6th. BTIG Research assumed coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price target for the company. Langenberg & Company restated a “buy” rating and issued a $53.25 price target on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Finally, Ladenburg Thalmann Financial Services assumed coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They issued a “buy” rating and a $53.25 price target for the company. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Orthofix International N.V. has a consensus rating of “Buy” and a consensus target price of $51.30.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.
